StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$13.24−0.56 (-4.06%)

Close on Nov 17, 2026Market cap $2.00BP/E –Yield –

Biohaven total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Biohaven's total debt was $264.29M at Sep 30, 2026. For fiscal 2025 it was $238.90M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$238.90M–
FY2024Dec 31, 2024$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$264.29M-1.5%
Q2 FY2026Jun 30, 2026$259.48M+0.9%
Q1 FY2026Mar 31, 2026$241.91M–
Q4 FY2025Dec 31, 2025$238.90M–
Q3 FY2025Sep 30, 2025$268.27M–
Q2 FY2025Jun 30, 2025$257.07M–
Q4 FY2024Dec 31, 2024$0–

More Biohaven figures

See a number that looks wrong?